Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C23H26ClN7O5 |
| Molecular Weight | 515.9503 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COc1ccc(cc1Cl)CN=c2c(cnc(NC(CCC(=O)O)CO)[nH]2)C(=NCc3ncccn3)O
InChI
InChIKey=PRFBRQCNRFBCHL-UHFFFAOYSA-N
InChI=1S/C23H26ClN7O5/c1-36-18-5-3-14(9-17(18)24)10-27-21-16(22(35)28-12-19-25-7-2-8-26-19)11-29-23(31-21)30-15(13-32)4-6-20(33)34/h2-3,5,7-9,11,15,32H,4,6,10,12-13H2,1H3,(H,28,35)(H,33,34)(H2,27,29,30,31)
| Molecular Formula | C23H26ClN7O5 |
| Molecular Weight | 515.9503 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Jun 26 05:33:37 UTC 2021
by
admin
on
Sat Jun 26 05:33:37 UTC 2021
|
| Record UNII |
2W6HE7B39T
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2W6HE7B39T
Created by
admin on Sat Jun 26 05:33:37 UTC 2021 , Edited by admin on Sat Jun 26 05:33:37 UTC 2021
|
PRIMARY | |||
|
129012003
Created by
admin on Sat Jun 26 05:33:37 UTC 2021 , Edited by admin on Sat Jun 26 05:33:37 UTC 2021
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
BINDER->LIGAND |
For M16, protein binding was moderate and ranged from 82.6 to 85.7% 0.5 hr after avanafil administration.
BINDING
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE INACTIVE |
MAJOR
FECAL; PLASMA; URINE
|
